Parnax Lab

Parnax Lab Net Change in Cash

The Net Change in Cash of Parnax Lab (506128.BO) as of Nov 3, 2026 is 921,000.00 INR. In the previous year, Net Change in Cash was -8.22 M INR — a change of -111.21% (higher).

Net Change in Cash

921,000.00INR

YoY

-111.21%

Last updated:

Net Change in Cash of Parnax Lab is 2025 921,000.00 INR. Net Change in Cash of Parnax Lab was 2024 -8.22 M INR. It decreases by -111.21% higher compared to the previous year.

The Parnax Lab Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
5.26 M INR
Jan 1, 2019
-10.11 M INR
Jan 1, 2020
4.39 M INR
Jan 1, 2021
-2.05 M INR
Jan 1, 2022
41.81 M INR
Jan 1, 2023
-30.83 M INR
Jan 1, 2024
-8.22 M INR
Jan 1, 2025
921,000.00 INR
The Parnax Lab Net Change in Cash history
YEARNet Change in CashYoY
921,000.00INR-111.21%
-8.22 MINR-73.34%
-30.83 MINR-173.74%
41.81 MINR-2,135.29%
-2.05 MINR-146.82%
4.39 MINR-143.39%
-10.11 MINR-292.38%
5.26 MINR-16.28%
6.28 MINR-131.79%
-19.75 MINR-236.12%
14.51 MINR+336.58%
3.32 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Net Change in Cash of Parnax Lab is 921,000.00 INR in 2025.

Net Change in Cash of Parnax Lab changed from -8.22 M INR to 921,000.00 INR, representing a -111.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Parnax Lab

All Key Metrics — Parnax Lab